Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
NCT ID:
NCT01208051
Group ID:
EG004
Title:
Phase II Arm B (Cediranib Maleate Plus Lenalidomide Thru April 10, 2015)
Description:
Patients receive cediranib maleate 30 mg PO and lenalidomide 15 mg PO on days 1-21. Cycles repeat every 4 weeks in the absence of disease progression or unacceptable toxicity. NOTE: As of April 10, 2015, patients assigned to this arm are discontinued lenalidomide and continued on cediranib alone.
Cediranib: Given PO
Cediranib Maleate: Given PO
Laboratory Biomarker Analysis: Correlative studies
Lenalidomide: Given PO
Deaths Number Affected:
13
Deaths Number At Risk:
None
Serious Number Affected:
32
Serious Number At Risk:
69
Other Number Affected:
66
Other Number At Risk:
69
Study:
NCT01208051
Results Section:
NCT01208051
Adverse Events Module:
NCT01208051